GHP Healthcare & Pharma Awards 2023 Seaford believes its market-leading products, like Seacalphyx and DRYSOL, showcases its ability to create trusted solutions. It has a diverse market reach, supported by over 30 years of experience, and enabling it to cater to areas beyond its portfolio. It does this by remaining customer focused, prioritising unique needs, and cultivating loyalty and lasting relationships spanning trade levels from hospitals to online platforms. Such qualities truly set the company apart, effectively addressing healthcare gaps, building trust, and offering tailored solutions for professionals and consumers. In the past year, Seaford Pharmaceuticals has driven innovative research in dermatology, specifically focusing on using naturally derived compounds to combat topical anti-fungal conditions. It took a meticulous approach to this research, emphasizing the efficacy and safety at all times. Preliminary results are promising, and reinforcing its confidence in the compounds potential for effective topical anti-fungal treatments. Its dedication remains strong as it continues onwards, aligning with its goal to revolutionize dermatological interventions. It is also expanding its hospital division and increasing export activity, to further enhance its impact across healthcare sectors. Seaford Pharmaceuticals has a myriad of achievements behind it. It was a trailblazer in pioneering evidence-based probiotics in gastroenterology for pouchitis. It introduced high-bioavailability calcium citrate, and provided exclusive sodium thiosulphate supply in Canada. It created a proprietary branded line, using its own line of branded products with the addition of thoughtful extensions. Such milestones, along with its many esteemed awards, are indicative of its enduring commitment and resilience. The company is driven by an exceptional team and robust partnerships, which means it is now poised for a future permeated with boundary-pushing influence. Its continuing plans involve keeping at the vanguard of state-ofthe-art innovation, with research and development that can be leveraged to create transformative novel healthcare solutions. It is embarking on new projects that embrace the digital world, focused on personalised engagement, data insights, and intelligent automation. It hopes to adopt digital strategies that enhance customer satisfaction and operational efficiency. To protect enterprise, it will of course be prioritising cybersecurity, along with compliance and ethical considerations that safeguard operations and stakeholder trust. This will underscore the company’s IP, as well as clinical trials. As the double winner of Healthcare Marketing Specialists of the Year 2023 – Canada, and the Innovation Award in R&D Excellence 2023 – Canada, Seaford Pharmaceuticals is to be commended. With its groundbreaking products, carefully nurtured talent, and strategic initiatives, it is certainly positioned as a leader in the pharmaceutical landscape, and no doubt will seize the opportunity to excel furthermore, with its terrific contributions to impactful healthcare solutions. Company: Seaford Pharmaceuticals Inc Web Address: www.seaford.ca Contact Name: Tamara Seales “Seaford Pharmaceuticals remains steadfast in delivering high-quality healthcare solutions while navigating complex regulatory landscapes, distribution challenges, and economic dynamics. We view these challenges as opportunities to strengthen our resilience and uphold excellence in healthcare.”
RkJQdWJsaXNoZXIy MTUyMDQwMA==